'Oral anticoagulant' presentation slideshows

Warfarin, Your Days are Numbered!

Warfarin, Your Days are Numbered!. Linda R. Kelly PharmD PhC CACP Pharmacy Anticoagulation Specialist Presbyterian Healthcare System. Objectives. Identify and classify the available oral anticoagulants Evaluate patient characteristics that would suggest using one product over another

641 views • 58 slides

?????????????

?????????????. ?????? ???. ?????????? CHADS 2. CHADS 2 criteria C ongestive heart failure H ypertension A ge ?75 yrs D iabetes mellitus S troke/transient ischaemic attack. Score 1 1 1 1 2. 0 1 2 3 4 5 6. CHADS 2 score. 0. 5. 10. 15. 20. 25. 30.

654 views • 41 slides

HYPERTHYROIDISM

HYPERTHYROIDISM . (thyroid over activity, thyrotoxicosis). It is common, affecting perhaps 2-5% of all females at some time and with a sex ratio of 5 : 1. Most often between ages 20 and 40 years.

3.04k views • 40 slides

321 views • 31 slides

BLOOD COAGULATION, ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS .

1.04k views • 26 slides

Polly Rimtepathip Pharm D. Candidate September 16, 2011

Outpatient Versus Inpatient Treatment for Patients with Acute Pulmonary Embolism: an International, Open-label, Randomised , Non-inferiority trial. Aujesky D, Roy P, Veschuren F, et al. Lancet 2011; 378: 41-48. Polly Rimtepathip Pharm D. Candidate September 16, 2011.

387 views • 21 slides

Informing Patients about Their Medications Oral Anticoagulation Therapy

Informing Patients about Their Medications Oral Anticoagulation Therapy. Objectives. By the end of this session you should: Know why it is important to inform patients about their medicines Know what points to cover when newly prescribing a patient an oral anticoagulant.

478 views • 21 slides

Treatment and Secondary Prevention of Cancer-Associated Thrombosis

Treatment and Secondary Prevention of Cancer-Associated Thrombosis. Supplement to Module 6. Overview. Introduction UFH as initial treatment for VTE LMWH as initial treatment for VTE Fondaparinux as initial treatment for VTE Transition to long-term therapy with vitamin K antagonists

307 views • 17 slides

Thrombolytic drugs

Thrombolytic drugs. BY :DR. ISRAA OMAR. FIBRINOLYSIS AND THROMBOLYSIS. It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin ,which digest fibrin .

716 views • 14 slides

Developing a Message Strategy for Safer Oral Anticoagulant Use Summary Presentation

Developing a Message Strategy for Safer Oral Anticoagulant Use Summary Presentation. September 21, 2005. Key Research Questions. What is the optimum target audience to get the most behavior change?

267 views • 13 slides

Lana Castellucci, David Garcia, and Thomas L. Ortel

Request for PCORnet Collaborators: C omparison of O ral Anticoagulants for extended VE nous T hromboembolism (COVET). Lana Castellucci, David Garcia, and Thomas L. Ortel. Background. LOI/Application Due Date

134 views • 13 slides